THE MEDICAL NEWS

Rabies virus detection in cell cultures could soon become faster and more accessible, thanks to a world-first AI system developed by researchers at the University of Surrey's Institute for People-Centred AI (PAI) in collaboration with the Rabies and Viral Zoonoses team at the Animal and Plant Health Agency (APHA).

In an analysis of data on adolescents and young adults with breast cancer, lower income and younger age were linked with delays in care.

Amphista Therapeutics Limited ('Amphista'), a leader in the discovery and development of non-cereblon / VHL targeted protein degradation (TPD) medicines, today announced dosing of the first patient in a Phase 1 trial for its lead candidate, AMX-883. Initiated following authorization from the U.S. Food and Drug Administration in June 2026, the BRAMLIE trial will investigate the safety, pharmacokin…

Pediatricians urge against raw milk, highlighting its link to foodborne illnesses and advocating for pasteurized alternatives to safeguard children's health.

Weaker handgrip strength correlates with severe long COVID symptoms, highlighting its potential as a measure for muscle dysfunction and recovery challenges.

Findings from a nationwide study suggest HPV vaccination may reduce adverse pregnancy outcomes, emphasizing its importance in reproductive health strategies.

A study of more than 25,000 analytical group assignments involving high-risk adults with type 2 diabetes found that sustained real-time continuous glucose monitoring (rtCGM) was associated with substantial improvements in blood sugar control over three years. Continued use was also linked to lower levels of a marker of kidney damage after three years, although researchers found no evidence that t…

In a randomized trial of 106 adolescents and young adults with hereditary cancer predisposition, adding AYA-RISE to a clinic visit improved knowledge of cancer risk before age 30 compared with a clinic visit alone. Researchers observed no increase in distress, but the main analyses did not establish additional benefits for lifetime-risk or screening knowledge.

Researchers developed EpiScreen, an AI system that distinguished epilepsy from psychogenic non-epileptic seizures using clinical notes from 13,633 patient records across two institutions. AI assistance improved neurologists’ classification accuracy in a retrospective assessment of 300 cases, but prospective studies must establish its performance and benefits in routine clinical care.

In a two-year randomized trial combining assisted weight management with an unassisted follow-up year, completers maintained average weight losses of 4.8 kg with diet drinks and 3.7 kg with water. Researchers found no significant difference between groups, but fewer than half of the 493 participants completed follow-up.